Got five minutes to read the latest news from the genomics world and beyond? Week in Brief has everything you need!
The application of AI has been a hot topic this week…
In a bid to better understand the potential of AI in healthcare settings, researchers have discovered that some of these tools can make accurate diagnoses from textbook-like descriptions of illness, but are less effective when presented with a summary generated by the patient themselves (AJHG).
However, this week’s news also featured a study that showed that an AI model was capable of diagnosing the genetic disorder Marfan syndrome using just facial photographs (Yale School of Medicine).
And we have learned more about how genetic variation impacts our health and wellbeing…
A large-scale genome wide association study has revealed several genetic associations to normal pressure hydrocephalus, a rare, chronic brain condition that impacts elderly individuals (Neurology).
A recent study has shown that certain genetic variants, known as high proportion spliced-in titin truncating variants, are linked to an increased risk of cardiovascular disease (Nature Cardiovascular Research).
A study using genomic data from several international sources has revealed new, rare genetic variants that are linked to the onset of Parkinson’s disease (npj Parkinson’s Disease).
Scientists have discovered that knocking out the gene ASTN2 in mice leads to traits associated with autism spectrum disorder (PNAS).
What about the use of genomic data in the clinic?
PARP inhibition has successfully been used to treat a paediatric neuroblastoma patient. The results suggest this therapy, application of which was guided by clinical genomics, could one day help more patients (NEJM).
Plus, new recommendations have been published regarding the reporting of next generation sequencing data. The guidelines aim to help clinicians make better decisions for treatment and diagnosis (Annals of Oncology).
And that’s not all…
Researchers have leveraged a deep learning approach to assess brain aging patterns in a cohort of nearly 50,000 individuals. The findings could be used to inform diagnoses and precision treatments (Nature Medicine).
Using a drug already approved for use by cancer patients, scientists have improved the function of cultured blood stem cells. Adding this drug to blood stem cell gene therapy protocols could therefore lead to better outcomes (Blood).
Using data from over 78,000 individuals in the Genomics England dataset, researchers have built a new haplotype reference panel for the UK Biobank. The new panel contains hundreds of millions of autosomal variants, is more accurate and diverse than previous panels (Nature Genetics).
Finally, researchers have compared the epigenomes of individuals who smoke or vape, determining that similar changes occur in both groups. Notably, vapers suffer from epigenomic dysregulation of a tumour suppressor gene that is linked to smoking-related cancers. (American Journal of Respiratory Cell and Molecular Biology).
Check out last week’s Week in Brief here.




